Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1161-1167

  Tängdén, Thomas ^a   Eriksson, Britt Marie ^a   Melhus, Åsa ^a   Svennblad, Bodil ^a   Cars, Otto ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

ESBLs; Interrupted time series; Piperacillin tazobactam

Indexed keywords

CARBAPENEM; CEFOTAXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DRUG USE; ESCHERICHIA COLI; FOLLOW UP; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; NONHUMAN; PNEUMONIA; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; PYREXIA IDIOPATHICA; SEPSIS; SEPTIC SHOCK; TERTIARY HEALTH CARE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DISEASE OUTBREAKS; DRUG UTILIZATION; EDUCATION; HOSPITALS; HUMANS; INTERVENTION STUDIES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 79954575386     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr053     Document Type: Article

References (19)

1. Rodriguez-Bano J, Navarro MD, Romero L et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichiacoli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006; 42: 37-45.
2. Rodriguez-Bano J, Navarro MD, Romero L et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clin Microbiol Infect 2008; 14: 180-3.
3. Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
4. Lautenbach E, Patel JB, Bilker WB et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71.
5. Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233-7.
6. Pena C, Pujol M, Ardanuy C et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extendedspectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 53-8.
7. Patterson JE, Hardin TC, Kelly CA et al. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000; 21: 455-8.
8. Bantar C, Vesco E, Heft C et al. Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance. Antimicrob Agents Chemother 2004; 48: 392-5.
9. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28: 1062-6.
10. Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005; issue 4: CD003543.
11. Davey P, Brown E, Fenelon L et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis 2006; 12: 211-6.
12. Ramsay C, Brown E, Hartman G et al. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003; 52: 764-71.
13. Lytsy B, Sandegren L, Tano E et al. The first major extended-spectrum β-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008; 116: 302-8.
14. Ransjo U, Lytsy B, Melhus A et al. Hospital outbreak control requires joint efforts from hospital management, microbiology and infection control. J Hosp Infect 2010; 76: 26-31.
15. Wagner AK, Soumerai SB, Zhang F et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27: 299-309.
16. Högberg L, Oke T, Geli P et al. Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002. J Antimicrob Chemother 2005; 56: 208-15.
17. Newey WK, West KD. Automatic lag selection in covariance matrix estimation. Rev Econ Stud 1994; 61: 631-53.
18. Lee J, Pai H, Kim YK et al. Control of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 2007; 60: 629-37.
19. Kim JY, Sohn JW, Park DW et al. Control of extended-spectrum β-lactamase-producing Klebsiella pneumoniae using a computerassisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 2008; 62: 416-21.